Sara L. Van Driest - Concepedia

Author

Sara L. Van Driest

Vanderbilt University Medical Center ORCID

Also Known As

Cherry Beasley, Nina Sperber, S L Van Driest, S Van Driest, S.L. Van Driest, Sara L Van Driest, Sara L. Van Driest, Sara L. Van Driest, Sara L. van Driest, Sara Van Driest

182

Publications

7.1K

Citations

H-Index

132

Concepts

All Affiliations

Vanderbilt University Medical Center Vanderbilt University Cincinnati Children's Hospital Medical Center Mayo Clinic University of Pennsylvania

About

Sara L. Van Driest is an author at Vanderbilt University Medical Center specializing in medicine, genetics, and pediatrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	37	2.9K
2	Public Health	11	11	1.1K
3	Engineering	2	2	168
4	Health Sciences	1	1	20
5	Social Sciences	1	1	26

Sara L. Van Driest

Publications

5.7K

Citations

H-Index

Page 1

	Year	Citations
Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy Sara L. Van Driest, Vlad C. Vasile, Steve R. Ommen, Journal of the American College of Cardiology Cardiac MuscleCardiomyopathyHeart FailureMolecular PhysiologyGenetics	2004	426
Return of Genomic Results to Research Participants: The Floor, the Ceiling, and the Choices In Between Gail P. Jarvik, Laura M. Amendola, Jonathan S. Berg, The American Journal of Human Genetics Genomic ResultsGenetic TestingResearch ParticipantsGeneticsStatistical Genetics	2014	368
Clinical Pharmacogenetics Implementation Consortium Guideline for <i>CYP2D6</i>, <i>OPRM1</i>, and <i>COMT</i> Genotypes and Select Opioid Therapy Kristine R. Crews, Andrew A. Monte, Rachel Huddart, Clinical Pharmacology & Therapeutics	2021	366
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2C19</i> and Proton Pump Inhibitor Dosing John J. Lima, Cameron D. Thomas, Julia M. Barbarino, Clinical Pharmacology & Therapeutics	2020	281
Phenotype risk scores identify patients with unrecognized Mendelian disease patterns Lisa Bastarache, Jacob Hughey, Scott J. Hebbring, Science Genome-wide Association StudyMendelian DisorderGenotype-phenotype AssociationDisease Risk AssessmentPolygenic Risk	2018	235
Echocardiography-Guided Genetic Testing in Hypertrophic Cardiomyopathy: Septal Morphological Features Predict the Presence of Myofilament Mutations Josepha Binder, Steve R. Ommen, Bernard J. Gersh, Mayo Clinic Proceedings Myofilament MutationsCardiomyopathyStructural Heart DiseaseGeneticsEchocardiography-guided Genetic Testing	2006	232
Prevalence and Spectrum of Thin Filament Mutations in an Outpatient Referral Population With Hypertrophic Cardiomyopathy Sara L. Van Driest, Erik G. Ellsworth, Steve R. Ommen, Circulation	2003	230
Comprehensive Analysis of the Beta-Myosin Heavy Chain Gene in 389 Unrelated Patients With Hypertrophic Cardiomyopathy Sara L. Van Driest, Michele A. Jaeger, Steve R. Ommen, Journal of the American College of Cardiology Cardiac MuscleCardiomyopathyHeart FailureUnrelated PatientsGenetics	2004	194
Prevalence and Severity of “Benign” Mutations in the β-Myosin Heavy Chain, Cardiac Troponin T, and α-Tropomyosin Genes in Hypertrophic Cardiomyopathy Sara L. Van Driest, Michael J. Ackerman, Steve R. Ommen, Circulation	2002	183
Yield of Genetic Testing in Hypertrophic Cardiomyopathy Sara L. Van Driest, Steve R. Ommen, A. Jamil Tajik, Mayo Clinic Proceedings CardiomyopathyGenetic TestingGeneticsGenetic EpidemiologyMedicine	2005	172

Page 1